Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes

被引:63
|
作者
Beggah, AT
Escoubet, B
Puttini, S
Cailmail, S
Delage, V
Ouvrard-Pascaud, A
Bocchi, B
Peuchmaur, M
Delcayre, C
Farman, N
Jaisser, F [1 ]
机构
[1] Inst Natl Sante & Rech Med, U478, F-75870 Paris, France
[2] Inst Natl Sante & Rech Med, U426, F-75870 Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Federat Inst Res 02, F-75870 Paris, France
[4] Federat Inst Res, U127, Int Natl Sante & Rech Med, F-75010 Paris, France
[5] Hop Robert Debre, Pathol Unit, F-75019 Paris, France
关键词
D O I
10.1073/pnas.102673599
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cardiac failure is a common feature in the evolution of cardiac disease. Among the determinants of cardiac failure, the renin-angiotensin-aldosterone system has a central role, and antagonism of the mineralocorticoid receptor (MR) has been proposed as a therapeutic strategy. In this study, we questioned the role of the MR, not of aldosterone, on heart function, using an inducible and cardiac-specific transgenic mouse model. We have generated a conditional knock-down model by expressing solely in the heart an antisense mRNA directed against the murine MR, a transcription factor with unknown targets in cardiomyocytes. Within 2-3 mo, mice developed severe heart failure and cardiac fibrosis in the absence of hypertension or chronic hyperaldosteronism. Moreover, cardiac failure and fibrosis were fully reversible when MR antisense mRNA expression was subsequently suppressed.
引用
收藏
页码:7160 / 7165
页数:6
相关论文
共 50 条
  • [21] Increased aldosterone synthase and type I mineralocorticoid receptor expression in experimental chronic heart failure
    Bauersachs, J
    Kellner, M
    Wehling, M
    Fraccarollo, D
    Ertl, G
    Christ, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 235A - 235A
  • [22] Increased cardiac and pulmonary endothelin-1 mRNA expression in canine pacing-induced heart failure
    Huntington, K
    Picard, P
    Moe, G
    Stewart, DJ
    Albernaz, A
    Monge, JC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 : S424 - S426
  • [23] Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
    Wang, Bing H.
    Robert, Remy
    Marques, Francine Z.
    Rajapakse, Niwanthi
    Kiriazis, Helen
    Mackay, Charles R.
    Kaye, David M.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Transcriptome sequencing and lncRNA-miRNA-mRNA network construction in cardiac fibrosis and heart failure
    Wang, Shuo
    Lv, Tianjie
    Chen, Qincong
    Yang, Yan
    Xu, Lei
    Zhang, Xiaolei
    Wang, Enmao
    Hu, Xitian
    Liu, Yuying
    BIOENGINEERED, 2022, 13 (03) : 7118 - 7133
  • [25] Sodium-induced cardiac differential gene expression in the heart of normotensive mineralocorticoid treated mice
    Wang, Qing
    Domenighetti, Andrea A.
    Pedrazzini, Thierry
    Burnier, Michel
    JOURNAL OF HYPERTENSION, 2006, 24 : 88 - 88
  • [26] Estrogen Treatment Reverses Heart Failure-Induced Cardiac Fibrosis and Inflammation
    Iorga, Andrea
    Nadadur, Rangarajan
    Volz, Katharina
    Li, Jingyuan
    Eghbali, Mansoureh
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 140A - 140A
  • [27] Erythropoietin induced cardiac regeneration in heart failure is mediated through augmented VEGF production by cardiomyocytes
    Westenbrink, B. D.
    Ruifrok, W. P.
    De Boer, R. A.
    Schoemaker, R. G.
    Voors, A. A.
    Van Veldhuisen, D. J.
    Van Gilst, W. H.
    EUROPEAN HEART JOURNAL, 2008, 29 : 128 - 129
  • [28] Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats
    Tonnessen, T
    Christensen, G
    Oie, E
    Holt, E
    Kjekshus, H
    Smiseth, OA
    Sejersted, OM
    Attramadal, H
    CARDIOVASCULAR RESEARCH, 1997, 33 (03) : 601 - 610
  • [29] Deletion of the mineralocorticoid receptor in vascular smooth muscle cells improves coronary and cardiac function in mice with heart failure
    Gueret, A.
    Galmiche, G.
    Nicol, L.
    Harouki, N.
    Henry, J. P.
    Besnier, M.
    Thuillez, C.
    Richard, V.
    Mulder, P.
    Jaisser, F.
    Pascaud, A. Ouvrard
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 19 - 19
  • [30] Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure
    Kasama, Shu
    Toyama, Takuji
    Sumino, Hiroyuki
    Kumakura, Hisao
    Takayama, Yoshiaki
    Minami, Kazutomo
    Ichikawa, Shuichi
    Matsumoto, Naoya
    Sato, Yuichi
    Kurabayashi, Masahiko
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (01) : 244 - 249